Navigation Links
Novus Scientific Announces the Sales Launch for TIGR™ Matrix Surgical Mesh - World's 1st Long-Term Resorbable Synthetic Mesh
Date:6/17/2010

CANTON, Mass., June 17 /PRNewswire/ -- Novus Scientific, Inc. today announced the US sales launch of TIGR™ Matrix Surgical Mesh at the Abdominal Wall Reconstruction meeting, Washington DC.  In February 2010, the US Food and Drug Administration (FDA) cleared, TIGR™ Matrix Surgical Mesh for use in reinforcement of soft tissues where weakness exists.

"The TIGR™ prosthetic adds a tool to the surgeon's armamentarium that is currently missing – a long acting, synthetic, absorbable product that may not only be beneficial in hernia patients, but also for prophylaxis, potentially preventing the hernia from ever forming in the first place," said David Earle MD FACS, Assistant Professor of Surgery, Tufts University School of Medicine, Springfield, MA.

TIGR™ Matrix Surgical Mesh is knitted from two different resorbable fibers that degrade at different rates following implantation. This unique patented dual-fibre design provides an initial high strength / high stability configuration, with gradually increasing compliance over time as the device is resorbed.  The macroporous structure is designed to allow tissue integration for reliable tissue repair. 

"TIGR™ Matrix Surgical Mesh begins a new era in patient treatment. While there is a wide range of potential applications for such a unique product, at today's Abdominal Wall Reconstruction meeting there has been particular interest in use of TIGR™ Matrix for onlay or sublay reinforcement in conjunction with the component separation technique," said Jim Archetto, President of Novus Scientific, Inc.

"TIGR™ Matrix Surgical Mesh fills a gap between traditional permanent mesh and biologic prosthetics. This long-term resorbable synthetic mesh defines a new product category that has never existed before, and I see many potential applications for it,"  stated Karl Leblanc, MD, past president of the American Hernia Society.

About Novus Scientific

Novus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable synthetic medical devices.  Global HQ is in Singapore while European Headquarters and the core R&D function are in Uppsala, Sweden.  The company's roots are Swedish as all the founders of Novus Scientific are previous owners / senior managers / members of the soft tissue-engineering project within Uppsala-based, Radi Medical Systems AB (now owned by St. Jude Medical Inc). The US Division, Novus Scientific, Inc. is headquartered near Boston, one of the world's foremost medical research cities. From this hub, Novus Scientific, Inc. will distribute TIGR™ Matrix Surgical Mesh throughout the United States, Canada, and Latin America.

TIGR™ is a trademark of Novus Scientific Pte Ltd

Contact:  JIm Archetto, +1-781-577-2599, jim.archetto@novusscientific.com


'/>"/>
SOURCE Novus Scientific, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Novus Scientific Receives FDA Clearance for TIGR(TM) Matrix Surgical Mesh - Worlds 1st Long-Term Resorbable Synthetic Mesh
2. Derycz Scientific to Exhibit at Digital Pharma West and Digital Pharma East
3. Novo Nordisk partners with international scientific community for Victoza(R) cardiovascular outcomes trial
4. WorldHeart Appoints Dr. John Campbell Woodard as Senior Vice President of Scientific Affairs
5. Water Street Healthcare Partners Signs Definitive Agreement to Sell Sierra Scientific Instruments to Given Imaging
6. Derycz Scientific Featured in Pharmaceutical Manufacturing and Genetic Engineering & Biotechnology News
7. Regado Biosciences, Inc. Introduces REG2, Its Second Product Candidate, at the American College of Cardiology Conference, 59th Annual Scientific Session, in Atlanta, Georgia on March 15, 2010
8. InfraReDxs LipiScan(TM) Coronary Imaging System for Identification of Lipid Core Plaque to be Highlighted at 59th Annual Scientific Session of the American College of Cardiology
9. Caliper Life Sciences Forms Scientific Advisory Board for Next Generation Sequencing
10. CyberKnife Society Scientific Meeting to Highlight Clinical Results and Technical Innovations
11. Oramed Pharmaceuticals Expands Scientific Advisory Board With the Appointment of John Amatruda, M.D.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2017)... , April 19, 2017  IRIDEX Corporation (Nasdaq: ... financial results for the first quarter 2017 after the ... Company,s management team will host a corresponding conference call ... Investors interested in listening to the conference ... domestic callers or (703) 326-3030 for international callers, using ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
(Date:4/19/2017)... -- The Global Effective Microorganisms (EM) Market by ... covered and analysed the potential of Global Effective Microorganisms (EM) ... and growth factors. The report identifies and analyses the emerging ... global market. ... Tables and Figures, 6 Major Company Profiles, spread across 124 ...
Breaking Medicine Technology:
(Date:4/29/2017)... Orion, Michigan (PRWEB) , ... April 29, 2017 ... ... signs of fertility and infertility. These methods observe the naturally occurring signs ... in intercourse during the most fertile time. , Natural family planning and ...
(Date:4/29/2017)... ... ... More than half of Americans suffering from noise-induced hearing loss do not ... causes hearing loss? May 1 marks the beginning of Better Hearing & Speech Month—a ... as schedule a hearing evaluation for anyone with concerns about his/her hearing. , Approximately ...
(Date:4/28/2017)... ... April 28, 2017 , ... Accreditation Commission ... Home Care Association of America (HCAOA). This agreement allows HCAOA members to receive ... well as discounts on Accreditation University (AU) educational resources that help prepare HCAOA ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield ... credit rating of “A” and its outlook as “stable.” At the same time, the ... have fallen in recent years, dip below “capital adequacy” thresholds required for its strong ...
(Date:4/28/2017)... ... April 28, 2017 , ... Ushio America ... lamps offer an instant energy-saving solution for F32T8 fluorescent lamps on most instant-start ... ballasts. These 50,000 hour rated lamps utilize the existing electronic ballast, saving labor ...
Breaking Medicine News(10 mins):